Depression and nonadherence predict mortality in hemodialysis treated end-stage renal disease patients

Hemodialysis International

Volumn 16, Issue 3, 2012, Pages 387-393

  Rosenthal Asher, Deborah ^a   Ver Halen, Nisha ^a   Cukor, Daniel ^a  

^a SUNY Downstate Medical Center   (United States)

Author keywords

Depression; Epidemiology; Survival

Indexed keywords

ADULT; AGE; ARTICLE; CLINICAL EVALUATION; DEPRESSION; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GENDER; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NORTH AMERICA; TREATMENT REFUSAL; URBAN AREA;

DEPRESSION; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RISK FACTORS; SURVIVAL RATE;

EID: 84863446258     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2012.00688.x     Document Type: Article

References (31)

1. Cukor D, Coplan J, Brown C etal. Depression and anxiety in urban hemodialysis patients. Clin J Am Soc Nephrol. 2007; 2:484-490.
2. Cukor D, Peterson RA, Cohen SD, Kimmel PL. Depression in end-stage renal disease hemodialysis patients. Nat Clin Pract Nephrol. 2006; 2:678-687.
3. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction: Impact on 6-month survival. JAMA. 1993; 270:1819-1861.
4. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation. 1995; 91:999-1005.
5. Black SA, Markides KS, Ray LA. Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type-2 diabetes. Diabetes Care. 2003; 26:2822-2828.
6. Zhang X, Norris SL, Gregg EW, Cheng YJ, Beckles G, Kahn HS. Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol. 2005; 161:652-660.
7. Egede LE, Nietert PJ, Zheng D. Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care. 2005; 28:1339-1345.
8. Spiegel D, Giese-Davis J. Depression and cancer: Mechanisms and disease progression. Biol Psychiatry. 2003; 54:269-282.
9. Ver Halen N, Cukor D, Constantiner M, Kimmel PL. Depression and mortality in end-stage renal disease. Curr Psychiatry Rep. 2012; 14:36-44.
10. Burton HJ, Kline SA, Lindsay RM, Heidenheim AP. The relationship of depression to survival in chronic renal failure. Psychosom Med. 1986; 48:261-269.
11. Shulman R, Price JDE, Spinelli J. Biopsychosocial aspects of long-term survival on end-stage renal therapy. Psychol Med. 1989; 19:945-954.
12. Devins GM, Mann J, Mandin H, etal. Psychosocial predictors of survival in end-stage renal disease. J Nerv Ment Dis. 1990; 178:127-133.
13. Christensen AJ, Wiebe JS, Smith TW, Turner CW. Predictors of survival among hemodialysis patients: Effect of perceived family support. Health Psychol. 1994; 13:521-525.
14. Kimmel PL, Peterson RA, Weihs KL etal. Psychosocial factors, behavioral compliance and survival in urban hemodialysis patients. Kidney Int. 1998; 54:245-254.
15. Kimmel PL, Peterson RA, Weihs KL etal. Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients. Kidney Int. 2000; 57:2093-2098.
16. Boulware LE, Yongmei L, Fink NE etal. Temporal relation among depression symptoms, cardiovascular disease events, and mortality in end-stage renal disease: Contribution of reverse causality. Clin J Am Soc Nephrol. 2006; 1:496-504.
17. Hedayati SS, Bosworth HB, Briley LP etal. Death or hospitalization of patients on chronic hemodialysis is associated with a physician-based diagnosis of depression. Kidney Int. 2008; 74:930-936.
18. Young BA, Von Kordd M, Heckbert SR etal. Association of major depression and mortality in stage 5 diabetic chronic kidney disease. Gen Hosp Psychiatry. 2010; 32:119-124.
19. Lopes AA, Bragg J, Young E etal. Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int. 2002; 62:199-207.
20. Untas A, Thumma J, Rascle N etal. The associations of social support and other psychosocial factors with mortality and quality of life in the Dialysis Outcomes and Practice Patterns Study. Clin J Am Soc Nephrol. 2011; 6:142-152.
21. Friend R, Hatchett L, Wadhwa N, Wadhwa K, Suh H. Serum albumin and depression in end-stage renal disease. Adv Perit Dial. 1997; 13:155-157.
22. Kimmel P. Psychosocial factors in dialysis patients. Kidney Int. 2001; 59:1599-1613.
23. Davison SN, Jhangri GS. The impact of chronic pain on depression, sleep, and the desire to withdraw from dialysis in hemodialysis patients. J Pain Symptom Manage. 2005; 30:465-473.
24. Kouidi E, Iacovides A, Iordanidis P etal. Exercise renal rehabilitation program: Psychosocial effects. Nephron. 1997; 77:152-158.
25. Steele TE, Wuerth D, Finkelstein S etal. Sexual experience of the chronic peritoneal dialysis patient. J Am Soc Nephrol. 1996; 7:1165-1168.
26. Cukor D, Rosenthal DS, Jindal RM, Brown CD, Kimmel PL. Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients. Kidney Int. 2009; 75:1223-1229.
27. Beck AT, Steer R. Manual for the Beck Depression Inventory. San Antonio, TX: The Psychological Corporation; 1987.
28. Watnick S, Kirwin P, Mahnensmith R, Concato J. The prevalence and treatment of depression among patients starting dialysis. Am J Kidney Dis. 2003; 41:105-110.
29. Finkelstein F, Watnick S, Finkelstein S, Wuerth D. The treatment of depression in patients maintained on dialysis. J Psychosom Res. 2002; 53:957-960.
30. Peterson R, Kimmel PL, Sacks C, Mesquita M, Simmens S, Reiss D. Depression, perception of illness and mortality in patients with end -stage renal disease. Int J Psychiatry Med. 1991; 21:343-354.
31. Chisholm MA, Lance CE, Williamson GM, Mulloy LL. Development and validation of an immunosuppressant therapy adherence barrier instrument. Nephrol Dial Transplant. 2005; 20:181-188.